BIOMAT Database Logo BIOMAT Database Logo

[Dipyridamole and ischemic heart disease]. 1988

M Batlouni

UI MeSH Term Description Entries
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D004176 Dipyridamole A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752) Antistenocardin,Apo-Dipyridamole,Cerebrovase,Cléridium,Curantil,Curantyl,Dipyramidole,Kurantil,Miosen,Novo-Dipiradol,Persantin,Persantine,Apo Dipyridamole,Novo Dipiradol
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014664 Vasodilation The physiological widening of BLOOD VESSELS by relaxing the underlying VASCULAR SMOOTH MUSCLE. Vasodilatation,Vasorelaxation,Vascular Endothelium-Dependent Relaxation,Endothelium-Dependent Relaxation, Vascular,Relaxation, Vascular Endothelium-Dependent,Vascular Endothelium Dependent Relaxation

Related Publications

M Batlouni
[Detection of ischemic heart disease by dipyridamole echocardiography].
July 1994, Nihon rinsho. Japanese journal of clinical medicine,
M Batlouni
Hypertension and ischemic heart disease. Role of dipyridamole echocardiography test.
November 1994, Angiology,
M Batlouni
[Dipyridamole test in the diagnosis of ischemic heart disease].
February 1991, Kardiologiia,
M Batlouni
[Ischemic heart disease evaluated using dipyridamole-stress two-dimensional echocardiography].
January 1990, Journal of cardiology,
M Batlouni
Pharmacological preconditioning of ischemic heart disease by low-dose dipyridamole.
September 1996, International journal of cardiology,
M Batlouni
Dipyridamole-exercise association in the diagnosis of ischemic heart disease.
January 1990, Medecine interne,
M Batlouni
[How important is dipyridamole in patients with ischemic heart disease?].
May 1990, Casopis lekaru ceskych,
M Batlouni
An evaluation of dipyridamole (Persantine) in angina pectoris and ischemic heart disease.
September 1967, The Journal of the American Osteopathic Association,
M Batlouni
[Diagnosis of ischemic heart disease by dipyridamole-stress two-dimensional echocardiography].
January 1994, Journal of cardiology,
M Batlouni
[Significance of the dipyridamole test in diagnosing chronic ischemic heart disease].
February 1986, Vrachebnoe delo,
Copied contents to your clipboard!